Role of PPAR-related genes in chronic heart failure: evidence from large populations.
Bioinformatics
Biological
Heart Failure
Microenvironment
PPAR
Journal
BMC cardiovascular disorders
ISSN: 1471-2261
Titre abrégé: BMC Cardiovasc Disord
Pays: England
ID NLM: 100968539
Informations de publication
Date de publication:
10 11 2023
10 11 2023
Historique:
received:
27
03
2023
accepted:
10
10
2023
medline:
13
11
2023
pubmed:
11
11
2023
entrez:
10
11
2023
Statut:
epublish
Résumé
The role of PPAR signaling and its associated genes in the pathogenesis and progression of chronic heart failure (CHF) remains elusive. We accessed the gene expression profile and relevant baseline information of CHF samples from the Gene Expression Omnibus (GEO) database, specifically from the GSE57338 project. From GSE57338 project, we derived the expression value of 126 PPAR-related genes. A protein-protein interaction network was then established to illustrate potential protein interactions. ClueGO analysis results revealed that these genes predominantly participate in functions such as export across plasma membrane, regulation of lipid metabolic process, fatty acid metabolism, circulatory system vascular processes, alcohol metabolism, triglyceride metabolism and regulation of lipid localization and response to nutrient. Using the cytohubba plug-in in Cytoscape, we pinpointed ACADM, PPARG and CPT2 as potential central molecules in HF pathogenesis and progression. Subsequent Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analysis delved into the potential biological role of these three genes in CHF. Immune infiltration analysis suggested that the infiltration level of neutrophils and M2 macrophages might be notably influenced by these genes, thereby playing a role in the CHF mechanism. Our research provides a comprehensive insight into the significance of PPAR associated genes in CHF development. Notably, the genes ACADM, PPARG and CPT2 emerged as potential targets for clinical interventions.
Sections du résumé
BACKGROUND
The role of PPAR signaling and its associated genes in the pathogenesis and progression of chronic heart failure (CHF) remains elusive.
METHODS
We accessed the gene expression profile and relevant baseline information of CHF samples from the Gene Expression Omnibus (GEO) database, specifically from the GSE57338 project.
RESULTS
From GSE57338 project, we derived the expression value of 126 PPAR-related genes. A protein-protein interaction network was then established to illustrate potential protein interactions. ClueGO analysis results revealed that these genes predominantly participate in functions such as export across plasma membrane, regulation of lipid metabolic process, fatty acid metabolism, circulatory system vascular processes, alcohol metabolism, triglyceride metabolism and regulation of lipid localization and response to nutrient. Using the cytohubba plug-in in Cytoscape, we pinpointed ACADM, PPARG and CPT2 as potential central molecules in HF pathogenesis and progression. Subsequent Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analysis delved into the potential biological role of these three genes in CHF. Immune infiltration analysis suggested that the infiltration level of neutrophils and M2 macrophages might be notably influenced by these genes, thereby playing a role in the CHF mechanism.
CONCLUSIONS
Our research provides a comprehensive insight into the significance of PPAR associated genes in CHF development. Notably, the genes ACADM, PPARG and CPT2 emerged as potential targets for clinical interventions.
Identifiants
pubmed: 37950149
doi: 10.1186/s12872-023-03554-8
pii: 10.1186/s12872-023-03554-8
pmc: PMC10638691
doi:
Substances chimiques
PPAR gamma
0
Lipids
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
552Informations de copyright
© 2023. The Author(s).
Références
Nat Commun. 2021 Mar 12;12(1):1648
pubmed: 33712605
PPAR Res. 2014;2014:242790
pubmed: 25371662
Nucleic Acids Res. 2023 Jan 6;51(D1):D587-D592
pubmed: 36300620
OMICS. 2012 May;16(5):284-7
pubmed: 22455463
Circulation. 1978 Dec;58(6):965-70
pubmed: 152168
Circ Heart Fail. 2014 Jan;7(1):172-83
pubmed: 24284026
Protein Sci. 2019 Nov;28(11):1947-1951
pubmed: 31441146
Nucleic Acids Res. 2000 Jan 1;28(1):27-30
pubmed: 10592173
Cardiovasc Res. 2001 Dec;52(3):407-16
pubmed: 11738057
Int Immunopharmacol. 2002 Jul;2(8):1029-44
pubmed: 12349941
Circulation. 2016 Feb 23;133(8):706-16
pubmed: 26819374
Exp Clin Cardiol. 2004 Fall;9(3):169-73
pubmed: 19641720
JAMA Netw Open. 2022 Mar 1;5(3):e223849
pubmed: 35333364
BMC Syst Biol. 2014;8 Suppl 4:S11
pubmed: 25521941
Bioinformatics. 2009 Apr 15;25(8):1091-3
pubmed: 19237447
Nat Rev Cardiol. 2016 Jun;13(6):368-78
pubmed: 26935038
J Ethnopharmacol. 2021 Jan 30;265:113324
pubmed: 32890714
Eur Respir J. 2018 Apr 4;51(4):
pubmed: 29449428
Dev Cell. 2013 Jan 28;24(2):144-58
pubmed: 23318133
Biol Chem. 2019 Apr 24;400(5):663-675
pubmed: 30521471
Int J Mol Sci. 2018 Jul 10;19(7):
pubmed: 29996502
Sci Transl Med. 2018 Apr 25;10(438):
pubmed: 29695452
Int J Mol Sci. 2022 Jan 17;23(2):
pubmed: 35055179
Circ Res. 2016 Sep 16;119(7):853-64
pubmed: 27444755
Life Sci. 2019 Aug 15;231:116493
pubmed: 31153818
J Lipid Res. 2021;62:100069
pubmed: 33757734
Circulation. 2001 Mar 27;103(12):1695-701
pubmed: 11273999
Pharmacol Ther. 2020 Jan;205:107424
pubmed: 31629005
Methods Mol Biol. 2018;1711:243-259
pubmed: 29344893
Arterioscler Thromb Vasc Biol. 2021 Jan;41(1):317-330
pubmed: 33207934
Cells. 2020 Oct 28;9(11):
pubmed: 33126411
Circ Res. 2014 Jan 31;114(3):565-71
pubmed: 24481846
Diabetes. 2012 Dec;61(12):3260-9
pubmed: 22912419
Diabetes. 2021 Jan;70(1):214-226
pubmed: 33093014
Eur Heart J. 2017 Jan 14;38(3):187-197
pubmed: 28158426
Circ Res. 2016 Jun 24;119(1):159-76
pubmed: 27340274
PPAR Res. 2016;2016:6042162
pubmed: 27148361
Front Genet. 2021 Jul 09;12:680369
pubmed: 34306023
Pharmacol Res. 2016 Sep;111:76-85
pubmed: 27268145